(Q40987322)

reason for preferred rank

25 September 2017

title

Long-Term Clinical Experience with Atenolol-a New Selective β-1-Blocker with Few Side-Effects from the Central Nervous System (English)

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

9 April 2023

Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367088

9 April 2023

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

9 April 2023

author name string

N. C. Henningsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367088

9 April 2023

I. Mattiasson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A367088

9 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=367088

9 April 2023

publication date

1 January 1979

1 reference

full work available at URL

25 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1979.tb06004.x

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1979.tb06004.x/fullpdf

9 April 2023

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

9 April 2023

published in

Acta medica Scandinavica

1 reference

25 September 2017

volume

205

1 reference

25 September 2017

issue

1-2

1 reference

25 September 2017

page(s)

61-66

1 reference

Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris

25 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Prophylactic treatment of migraine with propranolol. A clinical trial

9 April 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug

9 April 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Cutaneous and ocular reactions to practolol.

9 April 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Practolol in the treatment of tachyarrhythmias in patients with bronchial asthma

9 April 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity

9 April 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Clinical evaluation of atenolol in hypertension

9 April 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Long-term Hypotensive Effect of Atenolol (ICI 66.082), a New β-adrenergic Blocking Agent

9 April 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Treatment of hypertension with propranolol and hydralazine

9 April 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol

9 April 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Renin concentrations and effects of propranolol and spironolactone in patients with hypertension

9 April 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Combined dihydralazine and propranolol in the treatment of hypertension

9 April 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

A comparison of the effect on airway resistance of a new beta blocking drug, ICI.50,172 and propranolol

9 April 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

A comparison of beta adrenergic blocking drugs in the treatment of hypertension

9 April 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Selective cardiac sympathetic blockade as an adjunct to bronchodilator therapy

9 April 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

9 April 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Treatment of Hypertension with Propranolol

9 April 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

NETHALIDE, A BETA ADRENERGIC BLOCKING AGENT

9 April 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Letter: Ocular reactions to beta-blocking drugs

9 April 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

Propranolol in hypertension: a study of long-term therapy, 1964-1970

9 April 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1979.TB06004.X

9 April 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=367088

9 April 2023

1 reference